Eiji Takeuchi

20PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 26, 2026
Tumor Necrosis on Routine Pretreatment CT as a Potential Prognostic Marker in Advanced NSCLC Treated With Immune Checkpoint Inhibitor Monotherapy: A Two-Center Retrospective Study.

|Mar 15, 2026
Incidence of RSV- and Influenza-Associated Hospitalizations With Community-Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan in 2022-2024: APSG-J2 Study.

Haruka Maeda, Shingo Masuda, Bhim Gopal Dhoubhadel

|Jul 15, 2025
Successful pembrolizumab treatment in a patient with ALK-positive lung adenocarcinoma: A case report and literature review.

Yugo Matsumura, Seiya Ichihara, Kaori Nii

|Jul 07, 2025
First-Line Osimertinib for EGFR-Mutated Squamous Cell Lung Carcinoma: A Case Report.

Yugo Matsumura, Seiya Ichihara, Kaori Nii

|Dec 17, 2024
Pathological Complete Response to a Single Dose of Pembrolizumab-Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report.

Yugo Matsumura, Seiya Ichihara, Kaori Nii

|Dec 13, 2023
An increased relative eosinophil count as a predictive dynamic biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

Eiji Takeuchi, Hirokazu Ogino, Kensuke Kondo

Pageof 4

Frequent Collaborators

4 joint publications

Yasuhiko Nishioka

3 joint publications

Hiroshi Nokihara

2 joint publications

Tsutomu Shinohara

2 joint publications

Yuko Toyoda